Neurostimulation Devices Market
                     Neurostimulation Devices Market Analysis 
by Product, Application Type (Pain 
Management, Epilepsy, Essential Tremor, 
Urinary and Fecal Incontinence, 
Depression, Dystonia, Gastroparesis, 
Parkinson's Disease) Type and End User: 
Forecast to 2026
www.reportsanddata.com
Market Summary
According to the current analysis of Reports and Data, the global Neurostimulation Devices market was 
valued at USD 4.98 Billion in 2018 and is expected to reach USD 12.7 Billion by the year 2026, at a CAGR 
of 12.4 %. Neurostimulation Devices - Neurostimulator or Neurostimulation are equipment that is used 
for neuromodulation. The process of making use of an implantable medical device to alter and modulate 
neural activities for therapeutic purposes is called neuromodulation. The recent emergence of 
Neurostimulation Devices as a neural activity modulator is a major disruptive finding in the healthcare 
sector. In line with this, market leaders, as well as emerging players, are developing mechanisms that can 
be used for neural activities modulation. For instance, Medtronic plc US-based medical device company 
launched EnterraII gastric neurostimulator, a programmable device that generates mild electrical pulses 
for gastric electrical stimulation to treat chronic, intractable nausea and vomiting due to gastroparesis.
Rising prevalence of chronic diseases and lifestyle health disorders, unmet needs of patients are pushing 
the technological development, significant focus of healthcare companies on development of novel 
mechanisms, upcoming patent expiry, availability of private as well public funds for research, and 
affirmative regulatory scenario all over the globe, are some of the notable factors boosting market 
growth in the industry. According to the American Academy of Neurology, stroke is listed as the third 
leading cause of death in U.S., with Alzheimer’s being ranked as the sixth leading cause of death. 
Statistics from the same source indicate that Parkinson’s affects nearly 1 million Americans annually 
with at least a minimum of 60,000 new cases that are reported annually. 
www.reportsanddata.com
Further key findings from the report suggest 
• Neurostimulation Devices market is growing at a CAGR of 13.6% in the Asia Pacific, followed by North 
America and Europe, with 12.3 % and 12.1% CAGR, respectively. Rising chronic disease prevalence 
across the globe is the prominent factor to accelerate the Neurostimulation Devices market growth 
during forecast period across all regions
• As of 2018, Spinal Cord Stimulators is the dominating Neurostimulation Devices, which holds 35.5% 
of the global market. European regional market is the chief revenue-generating source for this 
product segment, followed by North America, Asia-Pacific, and other regions
• Sacral Nerve Stimulators is expected to be the fastest-growing market segment during the forecast 
period 2019-2026, with a CAGR of 13.2%. However, associated stringent government regulation is a 
major challenge for the Neurostimulation Devices market growth of this market segment
• Pain Management application type segment was valued at USD 2.03 billion in 2018 and is expected to 
reach USD 5.3 billion by 2026
• The Asia Pacific is expected to account for 19.4% of the global Neurostimulation Devices market. 
Developing nations such as China and India are likely to observe high growth
www.reportsanddata.com
• Associated adverse effects related to Neurostimulation Devices and Availability of external substitutes 
is expected to hinder the market growth during the forecast period
• Key participants in Neurostimulation Devices include Medtronic PLC, BioControl Medical, St. Jude 
Medical, Spinal Modulation, Boston Scientific Corp., Synapse Biomedical Inc., Cochlear, Cyberonics, 
Inc., and Nevro Corp.
Free Report Sample PDF @ https://www.reportsanddata.com/sample-enquiry-form/2303 
Segments covered in the report
This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the 
market trends in each of the sub-segments from 2016 to 2026. For the purpose of this report, Reports 
and Data has segmented the Neurostimulation Devices market on the basis of type, Product type, 
Application type, end use, and region:
Product Type (Revenue, USD Million; 2016–2026)
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
www.reportsanddata.com
• Vagus Nerve Stimulators
• Gastric Electric Stimulators
Application Type (Revenue, USD Million; 2016–2026)
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease
• Others
Type (Revenue, USD Million; 2016–2026)
• Implantable
• External
End Use (Revenue, USD Million; 2016–2026)
• Hospitals/Clinics
www.reportsanddata.com
• Cognitive Care Centers
• Research Institutes
• Others
Regional Outlook (Revenue in USD Million; 2016–2026)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Spain
• Benelux
• Italy
• Rest of the Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
www.reportsanddata.com
• Taiwan
• Australia
• Rest of Asia-Pacific
• Middle East & Africa
• Saudi Arabia
• South Africa
• Egypt
• Israel
• Rest of MEA
• Latin America
• Brazil
• Argentina
• Rest of Latin America
Browse Complete Report @ https://
www.reportsanddata.com/report-detail/neurostimulation-devices-market 
www.reportsanddata.com
About Us
Reports and Data is a market research and 
consulting company that provides syndicated research 
reports, customized research reports, and consulting 
services. Our solutions purely focus on your purpose to 
locate, target and analyze consumer behavior shifts 
across demographics, across industries and help client’s 
make a smarter business decision. 
Contact US
We offer market intelligence studies ensuring relevant 
and fact-based research across a multiple industries John Watson
including Healthcare, Technology, Chemicals, Power, and Head of Business Development
Energy. We consistently update our research offerings to 
ensure our clients are aware about the latest trends Reports And Data | Web: 
existent in the market. Reports and Data has a strong www.reportsanddata.com
base of experienced analysts from varied areas of Direct Line: +1-212-710-1370
expertise. E-mail: [email protected]
www.reportsanddata.com